182 related articles for article (PubMed ID: 21967037)
1. Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal.
Wei QH; Wu N; Bian JM; Chen Y; Su RB; Li J
Addict Biol; 2013 Mar; 18(2):230-40. PubMed ID: 21967037
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus.
Uematsu N; Matsukawa N; Kanamori T; Arai Y; Sagisaka T; Toyoda T; Yoshida M; Ojika K
Brain Res; 2009 Dec; 1305():150-7. PubMed ID: 19815004
[TBL] [Abstract][Full Text] [Related]
3. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
[TBL] [Abstract][Full Text] [Related]
4. Directed neural lineage differentiation of adult hippocampal progenitor cells via modulation of hippocampal cholinergic neurostimulating peptide precursor expression.
Sagisaka T; Matsukawa N; Toyoda T; Uematsu N; Kanamori T; Wake H; Borlongan CV; Ojika K
Brain Res; 2010 Apr; 1327():107-17. PubMed ID: 20206149
[TBL] [Abstract][Full Text] [Related]
5. Suppressed phosphorylation of collapsin response mediator protein-2 in the hippocampus of HCNP precursor transgenic mice.
Kanamori T; Matsukawa N; Kobayashi H; Uematsu N; Sagisaka T; Toyoda T; Kato D; Oikawa S; Ojika K
Brain Res; 2010 Oct; 1355():180-8. PubMed ID: 20682295
[TBL] [Abstract][Full Text] [Related]
6. Decreased hippocampal cholinergic neurostimulating peptide precursor protein associated with stress exposure in rat brain by proteomic analysis.
Kim HG; Kim KL
J Neurosci Res; 2007 Oct; 85(13):2898-908. PubMed ID: 17628502
[TBL] [Abstract][Full Text] [Related]
7. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
Benavides M; Laorden ML; Milanés MV
J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
[TBL] [Abstract][Full Text] [Related]
8. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.
Madokoro Y; Yoshino Y; Kato D; Sato T; Mizuno M; Kanamori T; Shimazawa M; Hida H; Hara H; Yoshida M; Borlongan CV; Ojika K; Matsukawa N
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661900
[TBL] [Abstract][Full Text] [Related]
9. Chronic morphine administration induces over-expression of aldolase C with reduction of CREB phosphorylation in the mouse hippocampus.
Yang HY; Pu XP
Eur J Pharmacol; 2009 May; 609(1-3):51-7. PubMed ID: 19289113
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
11. Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.
Ghazal P; Ciccocioppo R; Ubaldi M
Peptides; 2013 Aug; 46():6-12. PubMed ID: 23684726
[TBL] [Abstract][Full Text] [Related]
12. Expression changes of hippocampal energy metabolism enzymes contribute to behavioural abnormalities during chronic morphine treatment.
Chen XL; Lu G; Gong YX; Zhao LC; Chen J; Chi ZQ; Yang YM; Chen Z; Li QL; Liu JG
Cell Res; 2007 Aug; 17(8):689-700. PubMed ID: 17667915
[TBL] [Abstract][Full Text] [Related]
13. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
14. Morphine modulates glutamate release in the hippocampal CA1 area in mice.
Guo M; Xu NJ; Li YT; Yang JY; Wu CF; Pei G
Neurosci Lett; 2005 Jun 10-17; 381(1-2):12-5. PubMed ID: 15882781
[TBL] [Abstract][Full Text] [Related]
15. HCNP precursor protein transgenic mice display a depressive-like phenotype in old age.
Matsukawa N; Furuya Y; Ogura H; Ojika K
Brain Res; 2010 Aug; 1349():153-61. PubMed ID: 20599825
[TBL] [Abstract][Full Text] [Related]
16. Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal.
Wang X; Liu Y; Lei Y; Zhou D; Fu Y; Che Y; Xu R; Yu H; Hu X; Ma Y
Neurosci Lett; 2008 Mar; 433(3):178-82. PubMed ID: 18276072
[TBL] [Abstract][Full Text] [Related]
17. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
18. Disruption of acute opioid dependence by antisense oligodeoxynucleotides targeting neurogranin.
Tang L; Shukla PK; Wang ZJ
Brain Res; 2007 Apr; 1143():78-82. PubMed ID: 17306231
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel molecular candidates for acute liver failure in plasma of BALB/c murine model.
Lv S; Wei L; Wang JH; Wang JY; Liu F
J Proteome Res; 2007 Jul; 6(7):2746-52. PubMed ID: 17569552
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention.
Bu Q; Yang Y; Yan G; Hu Z; Hu C; Duan J; Lv L; Zhou J; Zhao J; Shao X; Deng Y; Li Y; Li H; Zhu R; Zhao Y; Cen X
J Proteomics; 2012 Feb; 75(4):1330-42. PubMed ID: 22123079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
